Here are five key notes on the technology:
1. The Lamellar Titanium Technology is a three-dimensionally printed device. The implant powder grows through the selective application of high-energy laser beams to incorporate the porosity and surface roughness on the implant associated with bone growth activity.
2. K2M’s CASCADIA AN and TL Interbody Systems will be the first products to feature the Lamellar Titanium Technology.
3. The technology’s surface showed in peer-reviewed research increased osteoblastic activity more than other materials.
4. The Lamellar Titanium Technology incorporates 500 micron diameter pores that run through the implant walls, forming continuous channels from endplate to endplate that serve as a conduit for bony integration.
5. The CASCADIA interbodies’ design has approximately 70 percent porosity overall and decreases the radiographic signature when compared with equivalent traditional nonporous titanium designs.
“Because of [the Lamellar Titanium Technology], CASCADIA is an important addition to the interbody fusion market and strengthens our portfolio of products,” said K2M President and CEO Eric Major. “These latest developments, coupled with the recent introduction of several complex spine offerings, reflect another strong year of innovation for K2M.”
More articles on orthopedic devices:
Xtant Medical to participate in NASS meeting: 5 things to know
Nexxt Spine’s manufacturing process aids company growth: 5 key points
NuVasive’s cervical corpectomy cage receives FDA clearance
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
